FindTrial
Sign In

Research on the Comprehensive Chain Construction and Application of a Standardized System for HBV Marker Detection

Research on the Comprehensive Chain Construction and Application of a Standardized System for HBV Marker Detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115599
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B virus infection

Interventions

HBcAb Group:N/A
HBsAb Group:HBsAb positive
HBsAg Group:N/A
HBV DNA Group:N/A

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The test results for HBV markers (HBV DNA, HBsAg, anti-HBc, anti-HBs) are negative, weak positive/borderline, or positive; 2.The test results for HBV markers (HBV DNA, HBsAg, anti-HBc, anti-HBs) are negative, weak positive/borderline, or positive.

Exclusion criteria

Exclusion criteria: 1.Blood sample volume less than 2 mL. 2.Blood sample is contaminated or exhibits severe lipemia, hemolysis, or clotting.

Design outcomes

Primary

MeasureTime frame
Hepatitis B core antibody;Hepatitis B surface antigen;Hepatitis B virus nucleic acid;Hepatitis B surface antibody;—

Countries

China

Contacts

Public ContactWang Lunan

Beijing Hospital

lunan99@163.com+86 10 8513 3609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026